brain cancer	is a	cancer of brain and nervous system
glioblastoma	is a	malignant brain tumor
glioblastoma	associated with	EGFR amplification
glioblastoma	associated with	necrosis
glioblastoma	treated with	temozolomide
glioblastoma	treated with	radiotherapy
temozolomide	is a	alkylating agent
radiotherapy	is a	standard therapy
dexamethasone	used for	edema
edema	causes	increased intracranial pressure
glioblastoma	recurs	in brain
TTFields	used for	glioblastoma
TTFields	is a	device
MGMT promoter methylation	predicts	temozolomide response
MGMT promoter methylation	associated with	better prognosis
astrocytoma	is a	glioma
oligodendroglioma	is a	glioma
oligodendroglioma	has	1p/19q codeletion
1p/19q codeletion	associated with	chemosensitivity
IDH mutation	occurs in	lower-grade glioma
IDH mutation	indicates	better prognosis
DIPG	is a	pediatric brainstem tumor
medulloblastoma	is a	pediatric cerebellar tumor
meningioma	is a	typically benign tumor
schwannoma	is a	benign nerve sheath tumor
CNS lymphoma	is a	lymphoma of CNS
brain metastasis	is a	secondary brain tumor
surgery	aims for	gross total resection
gross total resection	improves	progression-free survival
subtotal resection	results in	residual tumor
biopsy	confirms	histology
MRI	detects	contrast enhancement
contrast enhancement	indicates	tumor vascularity
ring-enhancing lesion	is seen in	glioblastoma
peritumoral edema	correlates with	mass effect
mass effect	threatens	brain function
neurosurgery	performs	tumor resection
radiation therapy	reduces	tumor size
stereotactic radiosurgery	treats	small tumors
bevacizumab	used for	recurrent glioblastoma
PCV regimen	used for	oligodendroglioma
tumor treating fields	disrupts	mitosis
dexamethasone	reduces	edema
edema	worsens	symptoms
neoplasm	includes	brain cancer
pediatric age group	associated with	DIPG
adult age group	associated with	glioblastoma
radiation exposure	increases	brain cancer risk
NF1	predisposes to	glioma
NF2	predisposes to	vestibular schwannoma
Li-Fraumeni syndrome	increases	brain cancer risk
MRI	guides	biopsy decision
biopsy	provides	tissue diagnosis
histology	defines	tumor type
brainstem	site of	DIPG
cerebellum	site of	medulloblastoma
cerebral hemisphere	site of	glioblastoma
ventricles	affected by	tumor growth
meninges	involved in	meningioma
dura	invaded by	meningioma
glioblastoma	has	high vascularity
glioblastoma	has	necrosis
recurrence	occurs in	brain tumor
mortality	associated with	brain cancer
survival	depends on	extent of resection
extent of resection	influences	prognosis
MGMT promoter methylation	defines	temozolomide sensitivity
IDH mutation	defines	prognosis in glioma
1p/19q codeletion	defines	chemosensitive glioma
EGFR amplification	defines	GBM biology
TERT promoter mutation	associated with	glioblastoma prognosis
H3 K27M mutation	defines	diffuse midline glioma
PTEN loss	contributes to	tumor progression
P53 mutation	found in	astrocytoma
radiation necrosis	mimics	tumor progression
steroid therapy	reduces	intracranial pressure
intracranial pressure	affects	consciousness
neurosurgeon	performs	craniotomy
craniotomy	enables	tumor resection
neuroimaging	monitors	tumor response
pseudoprogression	mimics	progression on imaging
pseudoprogression	occurs after	radiotherapy
intensity-modulated radiotherapy	delivers	conformal dose
VEGF	promotes	tumor vascularity
bevacizumab	targets	VEGF
radiation	causes	radiation-induced necrosis
cognitive function	declines with	brain cancer
quality of life	improves with	treatment
chemotherapy	used for	brain cancer
temozolomide	side effects	nausea
nausea	observed with	chemotherapy
leukopenia	caused by	chemotherapy
seizure prophylaxis	considered in	brain tumor
antiepileptic drug	treats	seizures
Karnofsky performance status	predicts	survival
neuro-oncology	manages	brain cancer
clinical trial	offers	novel therapy
methylation profiling	informs	diagnosis
pediatric brain tumor	differs from	adult tumor
survivorship	addresses	late effects
